Literature DB >> 15868398

Importance of poly(ADP-ribose) polymerases in the regulation of DNA-dependent processes.

E Petermann1, C Keil, S L Oei.   

Abstract

Poly(ADP-ribosyl)ation of proteins is involved in the regulation of basal cellular processes and seems to be crucial for genomic integrity and cell survival. Several nuclear poly(ADP-ribose) polymerases (PARPs) are known which interact with various proteins involved in DNA metabolism. These proteins can be targets of poly(ADP-ribosyl)ation, which generally downregulates their activities. Accordingly, PARPs have been implicated in numerous processes involving chromosomal DNA, such as the regulation of chromatin structure, DNA repair, replication and transcription. PARP-1, the major cellular PARP, and PARP-2 are activated by DNA strand breaks. These enzymes have been shown to participate in DNA repair. PARP-1 has also been associated with DNA replication and recombination. Another outstanding feature of PARP-1 is its impact on the activities of transcription factors and on gene expression. Two other nuclear PARP enzymes, tankyrase-1 and tankyrase-2, are important for telomere maintenance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868398     DOI: 10.1007/s00018-004-4504-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  5 in total

Review 1.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Authors:  Jose Luis Zamorano; Patrizio Lancellotti; Daniel Rodriguez Muñoz; Victor Aboyans; Riccardo Asteggiano; Maurizio Galderisi; Gilbert Habib; Daniel J Lenihan; Gregory Y H Lip; Alexander R Lyon; Teresa Lopez Fernandez; Dania Mohty; Massimo F Piepoli; Juan Tamargo; Adam Torbicki; Thomas M Suter; Jose Luis Zamorano; Victor Aboyans; Stephan Achenbach; Stefan Agewall; Lina Badimon; Gonzalo Barón-Esquivias; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Scipione Carerj; Veronica Dean; Çetin Erol; Donna Fitzsimons; Oliver Gaemperli; Paulus Kirchhof; Philippe Kolh; Patrizio Lancellotti; Gregory Y H Lip; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Marco Roffi; Adam Torbicki; António Vaz Carneiro; Stephan Windecker
Journal:  Eur J Heart Fail       Date:  2016-08-27       Impact factor: 15.534

2.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Alberico L Catapano; Ian Graham; Guy De Backer; Olov Wiklund; M John Chapman; Heinz Drexel; Arno W Hoes; Catriona S Jennings; Ulf Landmesser; Terje R Pedersen; Željko Reiner; Gabriele Riccardi; Marja-Riita Taskinen; Lale Tokgozoglu; W M Monique Verschuren; Charalambos Vlachopoulos; David A Wood; Jose Luis Zamorano
Journal:  Atherosclerosis       Date:  2016-09-01       Impact factor: 5.162

3.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

4.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

5.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

  5 in total
  18 in total

1.  NSAIDs may regulate EGR-1-mediated induction of reactive oxygen species and non-steroidal anti-inflammatory drug-induced gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the chemoprevention of colorectal cancer.

Authors:  Vivek Vaish; Honit Piplani; Chandan Rana; Kim Vaiphei; Sankar Nath Sanyal
Journal:  Mol Cell Biochem       Date:  2013-02-23       Impact factor: 3.396

2.  Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels.

Authors:  Mindy Reynolds; Susan Armknecht; Tatiana Johnston; Anatoly Zhitkovich
Journal:  Mutagenesis       Date:  2012-01-11       Impact factor: 3.000

Review 3.  Harnessing synthetic lethal interactions in anticancer drug discovery.

Authors:  Denise A Chan; Amato J Giaccia
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

4.  A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid malignancies and peritoneal carcinomatosis.

Authors:  Kim A Reiss; Joseph M Herman; Marianna Zahurak; Anthony Brade; Laura A Dawson; Angela Scardina; Caitlin Joffe; Emily Petito; Amy Hacker-Prietz; Robert J Kinders; Lihua Wang; Alice Chen; Sarah Temkin; Naomi Horiba; Lillian L Siu; Nilofer S Azad
Journal:  Clin Cancer Res       Date:  2014-10-29       Impact factor: 12.531

5.  Sex-related differences in length and erosion dynamics of human telomeres favor females.

Authors:  Peter Möller; Susanne Mayer; Torsten Mattfeldt; Kathrin Müller; Peter Wiegand; Silke Brüderlein
Journal:  Aging (Albany NY)       Date:  2009-07-14       Impact factor: 5.682

6.  PARP inhibition during alkylation-induced genotoxic stress signals a cell cycle checkpoint response mediated by ATM.

Authors:  Michael J Carrozza; Donna F Stefanick; Julie K Horton; Padmini S Kedar; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2009-08-31

7.  A Review of Tandem Mass Spectrometry Characterization of Adenosine Diphosphate-Ribosylated Peptides.

Authors:  Shawna M Hengel; David R Goodlett
Journal:  Int J Mass Spectrom       Date:  2011-06-12       Impact factor: 1.986

Review 8.  Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.

Authors:  Hu Wang; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Jong-Hun Lee; Ah-Ng Tony Kong
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

Review 9.  New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors.

Authors:  Melissa S Bentle; Erik A Bey; Ying Dong; Kathryn E Reinicke; David A Boothman
Journal:  J Mol Histol       Date:  2006-07-26       Impact factor: 3.156

10.  Genomic organization and control of the grb7 gene family.

Authors:  E Lucas-Fernández; I García-Palmero; A Villalobo
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.